This company has been marked as potentially delisted and may not be actively trading. NASDAQ:ROSG (ROSG) (ROSG) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About (ROSG) Stock (NASDAQ:ROSG) 30 days 90 days 365 days Advanced Chart Get (ROSG) alerts:Sign Up Key Stats Today's Range$0.42▼$0.4450-Day Range$0.43▼$0.4352-Week Range$0.23▼$2.75Volume169,599 shsAverage Volume81,512 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Rosetta Genomics Ltd. provides therapeutic, diagnostic product development and medical research services. The company develops and commercializes new diagnostic tests based on various genomics markers, including DNA, microRNA and protein biomarkers and using various technologies, including, qPCR, microarrays, next generation sequencing and fluorescence in situ hybridization. It offers proprietary microRNA technologies, such as Rosetta Cancer Origin, mi-KIDNEY, and RosettaGX Reveal Test. The company was founded by Isaac Bentwich on March 9, 2000 and is headquartered in Rehovot, Israel. Read More Receive ROSG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (ROSG) and its competitors with MarketBeat's FREE daily newsletter. Email Address ROSG Stock News Headlinesfarting with DIRECT intense eye contact 👀💨 🤣 #shorts #funny #fartprankOctober 7, 2024 | msn.comWhat is Rosh Hashanah? Here's what to know about the Jewish holidayOctober 3, 2024 | yahoo.comHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.July 24 at 2:00 AM | Paradigm Press (Ad)Insigniam Consultants Join Prestigious CED Fellowship ProgramSeptember 29, 2024 | msn.comThis app’s 52% off and going to make your next vacation so much betterAugust 9, 2024 | nypost.comNNvidia's suspected 2025 processor is now rumoured to be built by Intel using off-the-peg Arm cores. Yes, an Nvidia chip built by IntelMay 28, 2024 | msn.comRosetta Genomics Ltd ROSGQFebruary 27, 2024 | morningstar.comMLife science company founder: Lowering cost of DNA sequencing leads to groundbreaking advancements in personalized medicineOctober 7, 2023 | bizjournals.comSee More Headlines ROSG Stock Analysis - Frequently Asked Questions How were (ROSG)'s earnings last quarter? (ROSG) (NASDAQ:ROSG) released its earnings results on Thursday, May, 19th. The medical research company reported ($0.18) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.16) by $0.02. The medical research company earned $2.60 million during the quarter, compared to analysts' expectations of $3.36 million. What other stocks do shareholders of (ROSG) own? Based on aggregate information from My MarketBeat watchlists, some other companies that (ROSG) investors own include Agenus (AGEN), Bausch Health Cos (BHC), Endocyte (ECYT), Intercept Pharmaceuticals (ICPT), BIOLASE (BIOL), Eyepoint Pharmaceuticals (EYPT) and (SCMP) (SCMP). Company Calendar Last Earnings5/19/2016Today7/24/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolNASDAQ:ROSG CIK1362959 Webwww.rosettagenomics.com Phone972732220700FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Beginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (NASDAQ:ROSG) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredFREE GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...GoldCo Precious Metals | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (ROSG) Please log in to your account or sign up in order to add this asset to your watchlist. Share (ROSG) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.